Cancer
- Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies (27 Feb 2023)
- The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies (05 Sep 2022)
- Self-Assembly System Based on Cyclodextrin for Targeted Delivery of Cannabidiol (05 Sep 2022)
- Cannabidiol Induces Cell Death in Human Lung Cancer Cells and Cancer Stem Cells (05 Sep 2022)
- The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects (27 Aug 2022)
- Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment (27 Aug 2022)
- Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review (13 Aug 2022)
- Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
- Medical Cannabis in Pediatric Oncology: Friend or Foe? (05 Aug 2022)
- Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis (05 Aug 2022)
- Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review (31 Jul 2022)
- In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer (31 Jul 2022)
- Impact of Cannabinoid Compounds on Skin Cancer (31 Jul 2022)
- Effect of combining CBD with standard breast cancer therapeutics (31 Jul 2022)
- Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review - Journal of Cannabis Research (26 Jul 2022)
- Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer - Journal of Cannabis Research (26 Jul 2022)
- Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo (25 Jul 2022)
- ICRS 2019: CBD for Anxiety, Cancer, Heart Disease, Addiction... (21 Jul 2022)
- Encouraging Cancer Research (21 Jul 2022)
- Cannabis and Cannabinoids (PDQ®)–Patient Version (21 Jul 2022)
- Daily use of cannabidiol (‘CBD’) oil may be linked to lung cancer regression (18 Jul 2022)
- Customized Phytocannabinoid Profiles: A Novel Source of Precision Therapeutics for Specific Cancer Subtypes? (18 Jul 2022)
- CBD shows promise for fighting aggressive brain cancer (18 Jul 2022)